Welcome to LookChem.com Sign In|Join Free

CAS

  • or
FMOC-THR(TBU)-OL is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

189337-28-8 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • Carbamic acid,[(1R,2R)-2-(1,1-dimethylethoxy)-1-(hydroxymethyl)propyl]-,9H-fluoren-9-ylmethyl ester (9CI)/ LIDE PHARMA- Factory supply / Best price

    Cas No: 189337-28-8

  • USD $ 10.0-10.0 / Gram

  • 1 Gram

  • 10 Metric Ton/Day

  • LIDE PHARMACEUTICALS LIMITED
  • Contact Supplier
  • 9H-fluoren-9-ylmethyl N-[(2R,3R)-1-hydroxy-3-[(2-methylpropan-2-yl)oxy]butan-2-yl]carbamate

    Cas No: 189337-28-8

  • USD $ 1.9-2.9 / Gram

  • 100 Gram

  • 1000 Metric Ton/Month

  • Chemlyte Solutions
  • Contact Supplier
  • 189337-28-8 Structure
  • Basic information

    1. Product Name: FMOC-THR(TBU)-OL
    2. Synonyms: N-FMOC-L-THR(TBU)-OL;N-FMOC-L-THR(TBU)-OL-N-FMOC-(2R,3R)-2-AMINO-3-T-BUTOXY-1-BUTANOL;N-FMOC-(2R,3R)-2-AMINO-3-T-BUTOXY-1-BUTANOL;N-ALPHA-FMOC-O-T-BUTYL-L-THREONINOL;N-ALPHA-(9-FLUORENYLMETHYLOXYCARBONYL)-O-TERT-BUTYL-L-THREONINOL;N-(9-FLUORENYLMETHOXYCARBONYL)-O-T-BUTYL-L-THREONINOL;FMOC-(2R,3R)-2-AMINO-3-T-BUTOXY-1-BUTANOL;FMOC-O-T-BUTYL-L-THREONINOL
    3. CAS NO:189337-28-8
    4. Molecular Formula: C23H29NO4
    5. Molecular Weight: 383.48
    6. EINECS: N/A
    7. Product Categories: Amino Acids;Threonine [Thr, T];Amino Alcohols;Fmoc-Amino acid series
    8. Mol File: 189337-28-8.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 576.497 °C at 760 mmHg
    3. Flash Point: 302.454 °C
    4. Appearance: White to off-white powder
    5. Density: 1.144
    6. Vapor Pressure: 0mmHg at 25°C
    7. Refractive Index: 1.563
    8. Storage Temp.: Store at 0°C
    9. Solubility: N/A
    10. PKA: 11.00±0.46(Predicted)
    11. CAS DataBase Reference: FMOC-THR(TBU)-OL(CAS DataBase Reference)
    12. NIST Chemistry Reference: FMOC-THR(TBU)-OL(189337-28-8)
    13. EPA Substance Registry System: FMOC-THR(TBU)-OL(189337-28-8)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 189337-28-8(Hazardous Substances Data)

189337-28-8 Usage

Chemical Properties

White to off-white powder

Check Digit Verification of cas no

The CAS Registry Mumber 189337-28-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,9,3,3 and 7 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 189337-28:
(8*1)+(7*8)+(6*9)+(5*3)+(4*3)+(3*7)+(2*2)+(1*8)=178
178 % 10 = 8
So 189337-28-8 is a valid CAS Registry Number.
InChI:InChI=1/C23H29NO4/c1-15(28-23(2,3)4)21(13-25)24-22(26)27-14-20-18-11-7-5-9-16(18)17-10-6-8-12-19(17)20/h5-12,15,20-21,25H,13-14H2,1-4H3,(H,24,26)/t15-,21-/m1/s1

189337-28-8 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H52428)  (2R,3R)-2-(Fmoc-amino)-3-tert-butoxy-1-butanol, 97%   

  • 189337-28-8

  • 250mg

  • 740.0CNY

  • Detail
  • Alfa Aesar

  • (H52428)  (2R,3R)-2-(Fmoc-amino)-3-tert-butoxy-1-butanol, 97%   

  • 189337-28-8

  • 1g

  • 2220.0CNY

  • Detail
  • Alfa Aesar

  • (H52428)  (2R,3R)-2-(Fmoc-amino)-3-tert-butoxy-1-butanol, 97%   

  • 189337-28-8

  • 5g

  • 8879.0CNY

  • Detail

189337-28-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 9H-fluoren-9-ylmethyl N-[(2R,3R)-1-hydroxy-3-[(2-methylpropan-2-yl)oxy]butan-2-yl]carbamate

1.2 Other means of identification

Product number -
Other names N-[(1R,2R)-2-(1,1-Dimethylethoxy)-1-(hydroxymethyl)propyl]carbamic acid 9H-fluoren-9-ylmethyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:189337-28-8 SDS

189337-28-8Relevant articles and documents

Urea based foldamers

Yoo, Sung Hyun,Li, Bo,Dolain, Christel,Pasco, Morgane,Guichard, Gilles

, p. 59 - 92 (2021/06/25)

N,N′-linked oligoureas are a class of enantiopure, sequence-defined peptidomimetic oligomers without amino acids that form well-defined and predictable helical structures akin to the peptide α-helix. Oligourea-based foldamers combine a number of features—such as synthetic accessibility, sequence modularity, and folding fidelity—that bode well for their use in a range of applications from medicinal chemistry to catalysis. Moreover, it was recently recognized that this synthetic helical backbone can be combined with regular peptides to generate helically folded peptide-oligourea hybrids that display additional features in terms of helix mimicry and protein-surface recognition properties. Here we provide detailed protocols for the preparation of requested monomers and for the synthesis and purification of homo-oligoureas and peptide-oligourea hybrids.

POLYMYXIN-BASED COMPOUNDS USEFUL AS ANTIBACTERIAL AGENTS

-

Paragraph 0064-0065, (2020/04/30)

It relates to polymyxin analogues having a disulfide bond and an amino alcohol group adjacent to the disulfide bond, and optionally, an ester bond in the peptide backbone, which are useful as antibacterial agent, as well as to pharmaceutical compositions comprising them. It also relates to a key intermediate compound of formula (II) and its preparation process.

Staudinger/aza-Wittig reaction to access Nβ-protected amino alkyl isothiocyanates

Santhosh,Durgamma,Shekharappa,Sureshbabu, Vommina V.

, p. 4874 - 4880 (2018/07/15)

A unified approach to access Nβ-protected amino alkyl isothiocyanates using Nβ-protected amino alkyl azides through a general strategy of Staudinger/aza-Wittig reaction is described. The type of protocol used to access isothiocyanates depends on the availability of precursors and also, especially in the amino acid chemistry, on the behavior of other labile groups towards the reagents used in the protocols; fortunately, we were not concerned about both these factors as precursor-azides were prepared easily by standard protocols, and the present protocol can pave the way for accessing title compounds without affecting Boc, Cbz and Fmoc protecting groups, and benzyl and tertiary butyl groups in the side chains. The present strategy eliminates the need for the use of amines to obtain title compounds and thus, this method is step-economical; additional advantages include retention of chirality, convenient handling and easy purification. A few hitherto unreported compounds were also prepared, and all final compounds were completely characterized by IR, mass, optical rotation, and 1H and 13C NMR studies.

Synthesis method of Fmoc-O-tert-butyl-L-threoninol

-

Paragraph 0015, (2017/07/12)

The present invention relates to a synthesis method of Fmoc-O-tert-butyl-L-threoninol, and mainly solves the technical problems that in a process of Fmoc-thr(tbu)-oh reduction by sodium borohydride, the reaction temperature is strictly required and a FMoc protecting group is decomposed, resulting in low yield and high cost. The synthesis method of the invention comprises the following steps: a. L-threonine reacts with thionyl chloride to form L-threonine methyl ester hydrochloride; b. the L-threonine methyl ester hydrochloride under the action of sodium hydroxide is reacted with benzyl chloroformate to produce z-thr-ome; c. the Z-thr-ome reacts with introduced isobutene in the presence of methylene chloride and concentrated sulfuric acid, and alkali adjustment treatment is carried out to obtain z-thr (tbu)-ome; d. in the presence of acetone and water, the Z-thr(tbu)-ome is saponified with added alkali to obtain z-thr(tbu)-oh; e. the Z-thr(tbu)-oh is reduced to z-thr(tbu)-ol by sodium borohydride in tetrahydrofuran; f. the z-thr(tbu)-ol is hydrogenated in methanol to obtain H-thr(tbu)-ol; and g. N-(9-fluorenylmethoxycarbonyloxy)succinimide is added to the H-thr(tbu)-ol to obtain the Fmoc-O-tert-butyl -L-threoninol.

Synthesis of peptide alcohols on the basis of an O-N acyl-transfer reaction

Tailhades, Julien,Gidel, Marie-Aude,Grossi, Benjamin,Lecaillon, Jennifer,Brunel, Luc,Subra, Gilles,Martinez, Jean,Amblard, Muriel

supporting information; experimental part, p. 117 - 120 (2010/04/04)

(Figure Presented) Getting the better of troublemakers: C-terminal peptide alcohols cannot be synthesized by conventional solidphase peptide synthesis (SPPS) because of the absence of a free carboxylic group to attach to the resin. This problem was circumvented by anchoring a β-amino alcohol residue to the resin to provide a starting point for SPPS. An intramolecular O-N acyl shift completed the synthesis of the desired peptides (see scheme).

Solid phase method for synthesis peptide-spacer-lipid conjugates, conjugates synthesized thereby and targeted liposomes containing the same

-

Page 12, (2010/02/03)

A solid phase synthesis method for preparing peptide-spacer-lipid conjugates, the peptide-spacer-lipid conjugates synthesized by the method, and liposomes containing the peptide-spacer-lipid conjugates. The present invention provides a convenient solid phase synthesis method for preparing peptide-spacer-lipid conjugates and provides various linkage groups (such as amide group) for conjugating peptide, spacer and lipid, wherein the spacer may comprise PEG. Several advantages can be achieved, such as the synthetic procedure can be simplified, the synthesis process can be set to automation, the purification is easier in each reaction step, and the product losses can be reduced to minimal during synthesis. The present synthesis method is suitable for preparing a wide range of peptide-spacer-lipid conjugates, provides a peptide-spacer-lipid conjugate prepared by the solid phase synthesis method of the present invention, which can be incorporated into a liposome as the targeting moiety for liposomal drug delivery to specific cells, and provides a targeting liposome containing the present peptide-spacer-lipid conjugate.

Solid phase method for synthesis peptide-spacer-lipid conjugates, conjugates synthesized thereby and targeted liposomes containing the same

-

Page 13, (2010/02/03)

A solid phase synthesis method for preparing peptide-spacer-lipid conjugates, the peptide-spacer-lipid conjugates synthesized by the method, and liposomes containing the peptide-spacer-lipid conjugates. The present invention provides a convenient solid phase synthesis method for preparing peptide-spacer-lipid conjugates and provides various linkage groups (such as amide group) for conjugating peptide, spacer and lipid, wherein the spacer may comprise PEG. Several advantages can be achieved, such as the synthetic procedure can be simplified, the synthesis process can be set to automation, the purification is easier in each reaction step, and the product losses can be reduced to minimal during synthesis. The present synthesis method is suitable for preparing a wide range of peptide-spacer-lipid conjugates, provides a peptide-spacer-lipid conjugate prepared by the solid phase synthesis method of the present invention, which can be incorporated into a liposome as the targeting moiety for liposomal drug delivery to specific cells, and provides a targeting liposome containing the present peptide-spacer-lipid conjugate.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 189337-28-8